KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Cash & Equivalents (2021 - 2025)

Crescent Capital BDC's Cash & Equivalents history spans 5 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 50.22% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, down 50.22%, while the annual FY2025 figure was $5.0 million, 50.22% down from the prior year.
  • Cash & Equivalents reached $5.0 million in Q4 2025 per CCAP's latest filing, up from $2.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $17.1 million in Q3 2024 to a low of $2.1 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $7.0 million, with a median of $6.4 million recorded in 2021.
  • The largest YoY upside for Cash & Equivalents was 252.22% in 2025 against a maximum downside of 87.81% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $2.1 million in 2021, then surged by 202.46% to $6.4 million in 2022, then dropped by 19.84% to $5.1 million in 2023, then surged by 97.54% to $10.1 million in 2024, then crashed by 50.22% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCAP's Cash & Equivalents are $5.0 million (Q4 2025), $2.1 million (Q3 2025), and $9.7 million (Q2 2025).